Concepedia

Does drug price-regulation affect healthcare expenditures?

Omer Ben-Aharon, Oren Shavit, Racheli Magnezi

The European Journal of Health Economics · 2016 · 16 citations · 10 references

DOIFull text

Open access

Abstract

Maximum price and reimbursement mechanism regulations were not found to be associated with cost containment of national health expenditures. VBP may have the potential to do so over the long term.

References

10

A Strategy for Health Care Reform — Toward a Value-Based System

Michael E. Porter · New England Journal of Medicine · 2009 · 991 citations

, , +19

Beyond the income inequality hypothesis: class, neo-liberalism, and health inequalities

David Coburn · Social Science & Medicine · 2003 · 519 citations

, , +16

OFT, VBP: QED?

Karl Claxton · Health Economics · 2007 · 110 citations

, , +18

Health Technology Assessment in Health-Care Decisions in the United States

Sean D. Sullivan, John B. Watkins, Brian Sweet et al. · Value in Health · 2009 · 94 citations · Full text

, , +9

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation

Jörg Ruof, Friedrich Wilhelm Schwartz, J.-Matthias Graf von der Schulenburg et al. · The European Journal of Health Economics · 2013 · 86 citations · Full text